⌘K

Login Start Free

Home/Filings/4/0000950170-25-064567

4//SEC Filing

Apuli Maricel 4

Accession 0000950170-25-064567

CIK 0001743881other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 4:45 PM ET

Size

4.5 KB

Accession

0000950170-25-064567

Insider Transaction Report

Form 4

Period: 2025-05-02

BridgeBio Pharma, Inc.BBIO

Chief Accounting Officer

Transactions

Sale
Common Stock
2025-05-02$38.51/sh−1,026$39,509→ 147,639 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

BridgeBio Pharma, Inc.

CIK 0001743881

Entity typeother

Related Parties

1

filerCIK 0002058197

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 4:45 PM ET
Size: 4.5 KB

View on SEC.gov